Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
- Stat: 0.8%. That’s how much consumer spending fell in January 204—a much bigger dip than expected (CNBC).
CITE: https://www.r2library.com/Resource
CVS reported strong results for its healthcare segment in 2023, showing a 10.2% increase in revenue compared to the prior year. Still, executives lowered the segment’s 2024 guidance in anticipation of rising medical costs, according to earnings released this month.
Finally, the US stock market reopens today after the long weekend, and everyone’s still talking about the Magnificent Seven. That’s because, according to a new report from Deutsche Bank, profits at these seven tech giants are greater than the profits of all publicly traded companies in nearly every G20 country. And in terms of market value, they’d be the second-largest national stock exchange in the world. Goldman Sachs sees this party lasting all night: It raised its 2024 target for the S&P 500 for the second time.
COMMENTS APPRECIATED
Thank You
***
***
Share this:
Filed under: "Ask-an-Advisor", Drugs and Pharma, Experts Invited, Funding Basics, Information Technology, Investing, LifeStyle | Tagged: CNBC, consumer spending, consumer spending down, CVs, CVS Health, Deautsche Bank, Drugs, G20, Goldman Sachs, Magnificent 7, magnificent seven, PBM, pharma, pharmacy, Pharmacy Benefit Mangers, stock markets |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Leave a comment